The goal of this activity is for learners to be better able to summarize the clinical data and risk factors for amyloid-related imaging abnormalities (ARIA) and to develop a plan to monitor for ARIA in patients receiving anti-amyloid monoclonal antibody therapy.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1002072
- Start Date: 2024-12-24 06:00:00
- End Date: 2024-12-24 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: Lilly (Any division) - Amount: 106380.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest